JAK2V617F mutation associated with cerebral venous thrombosis: A report of five cases

Cerebrovascular Diseases

Volumn 29, Issue 2, 2010, Pages 206-209

  Godeneche, Gaelle ^a   Gaillard, N ^b   Roy, L ^a   Mania, A ^b   Tondeur, S ^c   Chomel, J C ^a   Lavabre, T ^d   Arquizan, C ^b   Neau, J P ^a  

^a POITIERS UNIVERSITY HOSPITAL   (France)

^b GUI DE CHAULIAC HOSPITAL   (France)

^c Laboratoire d'Hématologie

^d MONTPELLIER UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CASE REPORT; CLINICAL FEATURE; DNA EXTRACTION; FEMALE; GENE; GENE MUTATION; GENETIC ASSOCIATION; GENETIC SCREENING; HUMAN; JAK2 GENE; MALE; OCCLUSIVE CEREBROVASCULAR DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

AGED; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTRACRANIAL THROMBOSIS; JANUS KINASE 2; MALE; MIDDLE AGED; MUTATION; MYELOPROLIFERATIVE DISORDERS; PHENOTYPE; RISK FACTORS; TREATMENT OUTCOME; VENOUS THROMBOSIS;

EID: 72149098850     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000267281     Document Type: Article

References (15)

1. Tefferi A, Elliott M: Thrombosis in myeloproliferative disorders: prevalence, prognostic factors, and the role of leukocytes and JAK2 V617F . Semin Thromb Hemost 2007; 33: 313-320.
2. Kiladjian JJ, Cervantes F, Leebeek FW, Marzac C, Cassinat B, Chevret S, Cazals-Hatem D, Plessier A, Garcia-Pagan JC, Murad SD, Raffa S, Janssen HL, Gardin C, Cereja S, Tonetti C, Giraudier S, Condat B, Casadevall N, Fenaux P, Valla DC: The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis: A report on 241 cases. Blood 2008; 111: 4922-4929.
3. De Stefano V, Fiorini A, Rossi E, Za T, Chiusolo P, Sica S, Leone G: Incidence of JAK2 V617F mutation among patients with splanchnic or cerebral venous thrombosis and without overt chronic myeloproliferative disorders. J Thromb Haemost 2007; 5: 708-714.
4. Ferro JM, Canhao P, Stam J, Bousser MG, Barinagarrementeria F; ISCVT Investigators: Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke 2004; 35: 664-670.
5. Campell PJ, Green AR: The myeloproliferative disorders. N Engl J Med 2006; 355: 2452-2466.
6. Tefferi A, Vardiman JW: Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms. Leukemia 2008; 22: 14-22.
7. Baxter EJ, Scott LM, Campbell PJ, East C, Fourouclas N, Swanton S, Vassiliou GS, Bench AJ, Boyd EM, Curtin N, Scott MA, Erber WN, Green AR: Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet 2005; 365: 1054-1061.
8. Bousser MG, Ferro JM: Cerebral venous thrombosis: An update. Lancet Neurol 2007; 6: 162-170.
9. Colaizzo D, Amitrano L, Iannaccone L, Vergura P, Cappucci F, Grandone E, Guardascione MA, Margaglione M: Gain-of-function gene mutations and venous thromboembolism: distinct roles in different clinical settings. J Med Genet 2007; 44: 412-416.
10. Colaizzo D, Amitrano L, Tiscia GL, Scenna G, Grandone E, Guardascione MA, Brancaccio V, Margaglione M: The Jak2 V617F mutation frequently occurs in patients with portal and mesenteric venous thrombosis. J Thromb Haemost 2007; 5: 55-61.
11. Patel RK, Lea NC, Heneghan MA, Westwood NB, Milojkovic D, Thanigaikumar M, Yallop D, Arya R, Pagliuca A, Gäken J, Wendon J, Heaton ND, Mufti GJ: Prevalence of the activating JAK2 tyrosine kinase mutation V617F in the Budd-Chiari syndrome. Gastroenterology 2006; 130: 2031-2038.
12. De Stefano V, Rossi E, Za T, Chiusolo P, Leone G: The JAK2V617F mutation in patients with cerebral venous thrombosis: A rebuttal. Thromb Haemost 2008; 99: 1121.
13. Bellucci S, Cassinat B, Bonnin N, Marzac C, Crassard I: The V617F JAK2 mutation is not a frequent event in patients with cerebral venous thrombosis without overt chronic myeloproliferative disorder. Thromb Heamost 2008; 99: 1119-1120.
14. Ferro JM, Canhao P, Stam J, Bousser MG, Barinagarrementeria F; ISCVT Investigators: Cerebral vein and dural sinus thrombosis in elderly patients. Stroke 2005; 36: 1927-1932.
15. Kralovics R, Passamonti F, Buser AS, Teo SS, Tiedt R, Passweg JR, Tichelli A, Cazzola M, Skoda RC: A gain-of-function of JAK2 in myeloproliferative disorders. N Engl J Med 2005; 352: 1779-1790.